Glimepiride oral tablet is available as a generic drug and as a brand-name drug. Brand name: Amaryl. Glimepiride comes as a tablet you take by mouth. Glimepiride is used to treat type 2 diabetes. It ...

Objective: The aim of the present study was to monitor the efficacy and tolerability of glimepiride in daily practice. Design: An 8-week non-interventional cohort study investigating glimepiride in ...

The price you pay for glimepiride depends on several factors. These include your dosage, whether you have health insurance, and the pharmacy you use. Financial assistance may be available to help with ...

Learn everything you need to know about Glimepiride-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...

Sulfonylureas are often added to metformin to improve glycemic control, but at the known risk of increasing hypoglycemia and weight gain. In a report published in the Lancet, more than 1,500 patients ...

Long-term use of glimepiride may improve survival and reduce hospitalizations in hospitalized patients with concomitant type 2 diabetes and chronic HF, researchers reported. In addition, high-dose ...

Glimepiride (Dixi -2) is a sulfonylurea antidiabetic agent, prescribed for type 2 diabetes.It works by causing the pancreas to produce insulin. The information provided on this page is intended to ...

Heart Failure Linked to Loss of Cerebral Gray Matter The dipeptidyl peptidase-4 inhibitor linagliptin is noninferior to the sulphonylurea glimepiride for second-line glycemic control and is associated ...

Rosiglitazone (as maleate), glimepiride; 4mg/1mg, 4mg/2mg, 4mg/4mg, 8mg/2mg, 8mg/4mg; tabs. ≥18yrs: Take once daily with first meal of the day. Drug-naive: 4mg/1mg. Previously on thiazolidinedione ...

Please provide your email address to receive an email when new articles are posted on . More Chinese adults with type 2 diabetes reduced their HbA1c to below 7% while not gaining weight or ...

The efficacy and tolerability of glimepiride was confirmed in this 8-week non-interventional study of patients with type 2 diabetes mellitus. The reduction in HbA 1c levels over the period of the ...